The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Robert A. Hegele

Blackburn Cardiovascular Genetics Laboratory

Robarts Research Institute

London

Ontario

Canada

[email]@rri.on.ca

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Blackburn Cardiovascular Genetics Laboratory, Robarts Research Institute, London, Ontario, Canada. 1998 - 2002
  • Robarts Research Institute, University of Western Ontario, London, Canada. 1998 - 2002
  • Robarts Research Institute, London, UK. 2000
  • St. Michael's Hospital, Toronto, Ontario, Canada. 1998
  • Robarts Research Institute and Department of Medicine, Thames Valley Family Practice Research Unit, University of Western Ontario, London, Canada. 1998

References

  1. Environmental modulation of atherosclerosis end points in familial hypercholesterolemia. Hegele, R.A. Atheroscler. Suppl (2002) [Pubmed]
  2. Acanthocytosis in a patient with homozygous familial hypobetalipoproteinemia due to a novel APOB splice site mutation. Hegele, R.A., Miskie, B.A. Clin. Genet. (2002) [Pubmed]
  3. Variable association between genetic variation in the CYP7 gene promoter and plasma lipoproteins in three Canadian populations. Hegele, R.A., Wang, J., Harris, S.B., Brunt, J.H., Young, T.K., Hanley, A.J., Zinman, B., Connelly, P.W., Anderson, C.M. Atherosclerosis (2001) [Pubmed]
  4. Evidence for expanded clinical utility of statin drugs. Hegele, R.A. Curr. Atheroscler. Rep (2001) [Pubmed]
  5. Genes and environment in type 2 diabetes and atherosclerosis in aboriginal Canadians. Hegele, R.A. Curr. Atheroscler. Rep (2001) [Pubmed]
  6. Molecular basis of partial lipodystrophy and prospects for therapy. Hegele, R.A. Trends. Mol. Med (2001) [Pubmed]
  7. Premature atherosclerosis associated with monogenic insulin resistance. Hegele, R.A. Circulation (2001) [Pubmed]
  8. Polymorphisms in PNLIP, encoding pancreatic lipase, and associations with metabolic traits. Hegele, R.A., Ramdath, D.D., Ban, M.R., Carruthers, M.N., Carrington, C.V., Cao, H. J. Hum. Genet. (2001) [Pubmed]
  9. Single-nucleotide polymorphisms of the nuclear lamina proteome. Hegele, R.A., Yuen, J., Cao, H. J. Hum. Genet. (2001) [Pubmed]
  10. Common genomic variation in LMNA modulates indexes of obesity in Inuit. Hegele, R.A., Huff, M.W., Young, T.K. J. Clin. Endocrinol. Metab. (2001) [Pubmed]
  11. Single nucleotide polymorphisms of RXRA encoding retinoid X receptor alpha. Hegele, R.A., Cao, H. J. Hum. Genet. (2001) [Pubmed]
  12. Serum C-reactive protein in Canadian Inuit and its association with genetic variation on chromosome 1q21. Hegele, R.A., Ban, M.R., Young, T.K. Clin. Chem. (2001) [Pubmed]
  13. Monogenic dyslipidemias: window on determinants of plasma lipoprotein metabolism. Hegele, R.A. Am. J. Hum. Genet. (2001) [Pubmed]
  14. The private hepatocyte nuclear factor-1alpha G319S variant is associated with plasma lipoprotein variation in Canadian Oji-Cree. Hegele, R.A., Cao, H., Harris, S.B., Hanley, A.J., Zinman, B., Connelly, P.W. Arterioscler. Thromb. Vasc. Biol. (2000) [Pubmed]
  15. NAT2 polymorphism associated with plasma glucose concentration in Canadian Oji-Cree. Hegele, R.A., Kwan, K., Harris, S.B., Hanley, A.J., Zinman, B., Cao, H. Pharmacogenetics (2000) [Pubmed]
  16. Disparity between association and linkage analysis for HNF1A G319S in type 2 diabetes in Canadian Oji-Cree. Hegele, R.A., Hanley, A.J., Zinman, B., Harris, S.B., Anderson, C.M. J. Hum. Genet. (2000) [Pubmed]
  17. Association between nuclear lamin A/C R482Q mutation and partial lipodystrophy with hyperinsulinemia, dyslipidemia, hypertension, and diabetes. Hegele, R.A., Anderson, C.M., Wang, J., Jones, D.C., Cao, H. Genome Res. (2000) [Pubmed]
  18. Infection-susceptibility alleles of mannose-binding lectin are associated with increased carotid plaque area. Hegele, R.A., Ban, M.R., Anderson, C.M., Spence, J.D. J. Investig. Med. (2000) [Pubmed]
  19. Clinical utility of HNF1A genotyping for diabetes in aboriginal Canadians. Hegele, R.A., Cao, H., Hanley, A.J., Zinman, B., Harris, S.B., Anderson, C.M. Diabetes. Care (2000) [Pubmed]
  20. Peroxisome proliferator-activated receptor-gamma2 P12A and type 2 diabetes in Canadian Oji-Cree. Hegele, R.A., Cao, H., Harris, S.B., Zinman, B., Hanley, A.J., Anderson, C.M. J. Clin. Endocrinol. Metab. (2000) [Pubmed]
  21. Gender, obesity, hepatic nuclear factor-1alpha G319S and the age-of-onset of type 2 diabetes in Canadian Oji-Cree. Hegele, R.A., Cao, H., Harris, S.B., Zinman, B., Hanley, A.J., Anderson, C.M. Int. J. Obes. Relat. Metab. Disord. (2000) [Pubmed]
  22. LMNA R482Q mutation in partial lipodystrophy associated with reduced plasma leptin concentration. Hegele, R.A., Cao, H., Huff, M.W., Anderson, C.M. J. Clin. Endocrinol. Metab. (2000) [Pubmed]
  23. Heterogeneity of nuclear lamin A mutations in Dunnigan-type familial partial lipodystrophy. Hegele, R.A., Cao, H., Anderson, C.M., Hramiak, I.M. J. Clin. Endocrinol. Metab. (2000) [Pubmed]
  24. Genetic variation in LMNA modulates plasma leptin and indices of obesity in aboriginal Canadians. Hegele, R.A., Cao, H., Harris, S.B., Zinman, B., Hanley, A.J., Anderson, C.M. Physiol. Genomics (2000) [Pubmed]
  25. Insulin resistance in human partial lipodystrophy. Hegele, R.A. Curr. Atheroscler. Rep (2000) [Pubmed]
  26. Familial partial lipodystrophy: a monogenic form of the insulin resistance syndrome. Hegele, R.A. Mol. Genet. Metab. (2000) [Pubmed]
  27. The hepatic nuclear factor-1alpha G319S variant is associated with early-onset type 2 diabetes in Canadian Oji-Cree. Hegele, R.A., Cao, H., Harris, S.B., Hanley, A.J., Zinman, B. J. Clin. Endocrinol. Metab. (1999) [Pubmed]
  28. Increased plasma apolipoprotein B-containing lipoproteins associated with increased urinary albumin within the microalbuminuria range in type 2 diabetes. Hegele, R.A., Harris, S.B., Zinman, B., Hanley, A.J., Connelly, P.W. Clin. Biochem. (1999) [Pubmed]
  29. Association between AGT T235 variant and microalbuminuria in Canadian Oji-Cree with type 2 diabetes mellitus. Hegele, R.A., Harris, S.B., Hanley, A.J., Zinman, B. Clin. Biochem. (1999) [Pubmed]
  30. Genetic prediction of coronary heart disease: lessons from Canada. Hegele, R.A. Scand. J. Clin. Lab. Invest. Suppl. (1999) [Pubmed]
  31. Paraoxonase genes and disease. Hegele, R.A. Ann. Med. (1999) [Pubmed]
  32. Association between AGT codon 235 polymorphism and variation in serum concentrations of creatinine and urea in Canadian Oji-Cree. Hegele, R.A., Harris, S.B., Hanley, A.J., Zinman, B. Clin. Genet. (1999) [Pubmed]
  33. Absence of association between genetic variation in the LIPC gene promoter and plasma lipoproteins in three Canadian populations. Hegele, R.A., Harris, S.B., Brunt, J.H., Young, T.K., Hanley, A.J., Zinman, B., Connelly, P.W. Atherosclerosis (1999) [Pubmed]
  34. Genetic prediction of atherosclerosis: lessons from studies in native Canadian populations. Hegele, R.A. Clin. Chim. Acta (1999) [Pubmed]
  35. G-protein beta3 subunit gene splice variant and body fat distribution in Nunavut Inuit. Hegele, R.A., Anderson, C., Young, T.K., Connelly, P.W. Genome Res. (1999) [Pubmed]
  36. Lipoprotein-genotype associations in Trinidadian neonates. Hegele, R.A., Ban, M.R., Busch, C.P., Ramsewak, S., Ramdath, D.D. Clin. Biochem. (1999) [Pubmed]
  37. Genome-wide scanning for type 2 diabetes susceptibility in Canadian Oji-Cree, using 190 microsatellite markers. Hegele, R.A., Sun, F., Harris, S.B., Anderson, C., Hanley, A.J., Zinman, B. J. Hum. Genet. (1999) [Pubmed]
  38. Absence of association between genetic variation of the beta 3-adrenergic receptor and metabolic phenotypes in Oji-Cree. Hegele, R.A., Harris, S.B., Hanley, A.J., Azouz, H., Connelly, P.W., Zinman, B. Diabetes. Care (1998) [Pubmed]
  39. -6A promoter variant of angiotensinogen and blood pressure variation in Canadian Oji-Cree. Hegele, R.A., Harris, S.B., Hanley, A.J., Sun, F., Connelly, P.W., Zinman, B. J. Hum. Genet. (1998) [Pubmed]
  40. Elevated LDL triglyceride concentrations in subjects heterozygous for the hepatic lipase S267F variant. Hegele, R.A., Breckenridge, W.C., Cox, D.W., Maguire, G.F., Little, J.A., Connelly, P.W. Arterioscler. Thromb. Vasc. Biol. (1998) [Pubmed]
  41. G protein beta3 subunit gene variant and blood pressure variation in Canadian Oji-Cree. Hegele, R.A., Harris, S.B., Hanley, A.J., Cao, H., Zinman, B. Hypertension (1998) [Pubmed]
  42. Genetic variation in paraoxonase-2 is associated with variation in plasma lipoproteins in Canadian Oji-Cree. Hegele, R.A., Harris, S.B., Connelly, P.W., Hanley, A.J., Tsui, L.C., Zinman, B., Scherer, S.W. Clin. Genet. (1998) [Pubmed]
  43. A review of intestinal fatty acid binding protein gene variation and the plasma lipoprotein response to dietary components. Hegele, R.A. Clin. Biochem. (1998) [Pubmed]
 
WikiGenes - Universities